
Novartis “embarked on a campaign to undermine and divert attention” from a cheap drug for vision loss and maintain the …

The US Food and Drug Administration has shown Roche’s eye-condition drug Lucentis the green light to treat patients with diabetic …
Novartis’ Lucentis has been recommended for approval in Europe to treat people suffering from vison loss due to diabetes. The …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEO
Tridem begins phase Ib trial of Parkinson’s disease vaccine

